Metraipolis › archive › dc_d07aac2599dd

AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects — Europe PMC PMID:40817386

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40817386
DOI
10.1038/s41434-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-10T14:08:48.628Z
SHA-256 of the archived text
ec1213d5ecf3d26069e41696ffd9edbe53b05a4922d0116569c268b35a887b63
Stable URL of this page
https://metraipolis.com/documento/dc_d07aac2599dd

How to cite

AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects — Europe PMC PMID:40817386 — Europe PMC (en), https://europepmc.org/article/MED/40817386 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d07aac2599dd (Metraipolis archive dc_d07aac2599dd, sha256 ec1213d5ecf3d26069e41696ffd9edbe53b05a4922d0116569c268b35a887b63)
BibTeX
@misc{dcd07aac2599dd,
  title = {AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects — Europe PMC PMID:40817386},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40817386},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d07aac2599dd; sha256 ec1213d5ecf3d26069e41696ffd9edbe53b05a4922d0116569c268b35a887b63},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40817386. Agents can read the archived copy with the MCP tool read_document.